Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ON101 Cream for Chronic Diabetic Foot Ulcers
NCT01898923Phase 3Completed
- Sponsor
- Oneness Biotech Co., Ltd.
- Start
- Nov 2012
- Primary completion
- May 2020
- Countries
- 3
01
Overview
A Phase 3 trial of Fespixon in diabetic foot ulcer (DFU), sponsored by Oneness Biotech Co., Ltd.. Started Nov 2012; status: completed.
02
Drugs
Fespixon
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on NCT01898923.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01898923.